Fas and TRAIL 'death receptors' as initiators of inflammation: Implications for cancer

Seminars in Cell and Developmental Biology

Volumn 39, Issue , 2015, Pages 26-34

  Cullen, Sean P ^a   Martin, Seamus J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cancer; Cytokines; Death receptors; Fas; Inflammation; TRAIL

Indexed keywords

CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE; DEATH RECEPTOR; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; CANCER GROWTH; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; INFLAMMATION; MACROPHAGE; NEOPLASM; NEUTROPHIL; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TUMOR INVASION; WOUND HEALING; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; HUMANS; INFLAMMATION; NEOPLASMS; RECEPTORS, DEATH DOMAIN; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84928207348     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2015.01.012     Document Type: Review

References (121)

1. Altemeier W.A., Zhu X., Berrington W.R., Harlan J.M., Liles W.C. CD95 (FAS) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway. J Leukoc Biol 2007, 82:718-721.
2. Abrahams V.M., Straszewski S.L., Kamsteeg M., Hanczaruk B., Schwartz P.E., Rutherford T.J., et al. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res 2003, 63:5573-5581.
3. Acharyya S., Oskarsson T., Vanharanta S., Malladi S., Kim J., Morris P.G., et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 2012, 150:165-178.
4. Allavena P., Sica A., Garlanda C., Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 2008, 222:155-161.
5. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
6. Azijli K., Yuvaraj S., Peppelenbosch M.P., Würdinger T., Dekker H., Joore J., et al. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung cancer cells. J Cell Sci 2012, 125:4651-4661.
7. Baader E., Toloczko A., Fuchs U., Schmid I., Beltinger C., Ehrhardt H., et al. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects. Cancer Res 2005, 65:7888-7895.
8. Barnhart B.C., Legembre P., Pietras E., Bubici C., Franzoso G., Peter M.E. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 2004, 23:3175-3185.
9. Bayne L.J., Beatty G.L., Jhala N., Clark C.E., Rhim A.D., Stanger B.Z., et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012, 21:822-835.
10. Beg A.A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996, 274:782-784.
11. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol 2011, 12:715-723.
12. Berg D., Stühmer T., Siegmund D., Müller N., Giner T., Dittrich-Breiholz O., et al. Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways. FEBS J 2009, 276:6912-6927.
13. Brennan F.M., McInnes I.B. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008, 118:3537-3545.
14. Chen L., Park S.M., Tumanov A., Hau A., Sawada K., Feig C., et al. CD95 promotes tumour growth. Nature 2010, 465:492-496.
15. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., et al. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J 2002, 21:3704-3714.
16. Choi C., Xu X., Oh J.W., Lee S.J., Gillespie G.Y., Park H., et al. Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res 2001, 61:3084-3091.
17. Corsini N.S., Sancho-Martinez I., Laudenklos S., Glagow D., Kumar S., Letellier E., et al. The death receptor CD95 activates adult neural stem cells for working memory formation and brain repair. Cell Stem Cell 2009, 5:178-190.
18. Croft M., Duan W., Choi H., Eun S.Y., Madireddi S., Mehta A. TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol 2011, 33:144-152.
19. Cullen S.P., Henry C.M., Logue S.E., Kearney C.J., Leverkus M., Martin S.J. Fas/CD95-induced chemokines can serve as 'find-me' signals for apoptotic cells. Mol Cell 2012, 49:1034-1048.
20. Cvetanovic M., Ucker D.S. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J Immunol 2004, 172:880-889.
21. Desbarats J., Newell M.K. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 2000, 6:920-923.
22. Desbarats J., Birge R.B., Mimouni-Rongy M., Weinstein D.E., Palerme J.S., Newell M.K. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 2003, 5:118-125.
23. Dickens L.S., Boyd R.S., Jukes-Jones R., Hughes M.A., Robinson G.L., Fairall L., et al. A death effector domain chain DISC model reveals a crucial role for caspase-8 chain assembly in mediating apoptotic cell death. Mol Cell 2012, 47:291-305.
24. Dupont P.J., Warrens A.N. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Immunology 2007, 120:133-139.
25. Elliott M.R., Chekeni F.B., Trampont P.C., Lazarowski E.R., Kadl A., Walk S.F., et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461:282-286.
26. Ehrhardt H., Fulda S., Schmid I., Hiscott J., Debatin K.M., Jeremias I. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene 2003, 22:3842-3852.
27. Erwig L.P., Henson P.M. Clearance of apoptotic cells by phagocytes. Cell Death Differ 2008, 15:243-250.
28. Falschlehner C., Schaefer U., Walczak H. Following TRAIL's path in the immune system. Immunology 2009, 127:145-154.
29. Farley S.M., Dotson A.D., Purdy D.E., Sundholm A.J., Schneider P., Magun B.E., et al. Fas ligand elicits a caspase-independent proinflammatory response in human keratinocytes: implications for dermatitis. J Invest Dermatol 2006, 126:2438-2451.
30. Faouzi S., Burckhardt B.E., Hanson J.C., Campe C.B., Schrum L.W., Rippe R.A., et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001, 276:49077-49082.
31. Frankel B., Longo S.L., Ryken T.C. Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2. J Neurooncol 1999, 44:205-212.
32. Fricker N., Beaudouin J., Richter P., Eils R., Krammer P.H., Lavrik I.N. Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL. J Cell Biol 2010, 190:377-389.
33. Fujiwara M., Suemoto H., Muragaki Y., Ooshima A. Fas-mediated upregulation of vascular endothelial growth factor and monocyte chemoattractant protein-1 expression in cultured dermal fibroblasts: role in the inflammatory response. J Dermatol 2007, 34:99-109.
34. Fukuda A., Wang S.C., Morris J.P.t., Folias A.E., Liou A., Kim G.E., et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011, 19:441-455.
35. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012, 12:253-268.
36. Gardel M.L., Schneider I.C., Aratyn-Schaus Y., Waterman C.M. Mechanical integration of actin and adhesion dynamics in cell migration. Annu Rev Cell Dev Biol 2010, 26:315-333.
37. Geserick P., Hupe M., Moulin M., Wong W.W., Feoktistova M., Kellert B., et al. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 2009, 187:1037-1054.
38. Gialeli C., Theocharis A.D., Karamanos N.K. Roles of matrix metalloproteases in cancer progression and their pharmacological targeting. FEBS J 2011, 278:1742-1758.
39. Gonzalvez F., Lawrence D., Yang B., Yee S., Pitti R., Marsters S., et al. TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol Cell 2012, 48:888-899.
40. Gude D.R., Alvarez S.E., Paugh S.W., Mitra P., Yu J., Griffiths R., et al. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal. FASEB J 2008, 22:2629-2638.
41. Guicciardi M.E., Gores G.J. Life and death by death receptors. FASEB J 2009, 23:1625-1637.
42. Guo Z., Zhang M., Tang H., Cao X. Fas links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. Blood 2005, 106:2033-2041.
43. Hoogwater F.J., Nijkamp M.W., Smakman N., Steller E.J., Emmink B.L., Westendorp B.F., et al. Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells. Gastroenterology 2010, 138:2357-2367.
44. Hovelmeyer N., Hao Z., Kranidioti K., Kassiotis G., Buch T., Frommer F., et al. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J Immunol 2005, 175:5875-5884.
45. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-195.
46. Jourdan M., Veyrune J.L., De Vos J., Redal N., Couderc G., Klein B. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells. Oncogene 2003, 22:2950-2959.
47. Karin M., Lawrence T., Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124:823-835.
48. Kataoka T., Budd R.C., Holler N., Thome M., Martinon F., Irmler M., et al. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 2000, 10:640-648.
49. Kavuri S.M., Geserick P., Berg D., Dimitrova D.P., Feoktistova M., Siegmund D., et al. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. J Biol Chem 2011, 286:16631-16646.
50. Kinoshita H., Hirata Y., Nakagawa H., Sakamoto K., Hayakawa Y., Takahashi R., et al. Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis. PLoS ONE 2013, 8:e60914.
51. Kleber S., Sancho-Martinez I., Wiestler B., Beisel A., Gieffers C., Hill O., et al. Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 2008, 13:235-248.
52. Kovalenko A., Wallach D. If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation. Mol Cell 2006, 22:433-436.
53. Kovalovich K., Li W., DeAngelis R., Greenbaum L.E., Ciliberto G., Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 2001, 276:26605-26613.
54. Lauber K., Bohn E., Krober S.M., Xiao Y.J., Blumenthal S.G., Lindemann R.K., et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003, 113:717-730.
55. Lavrik I.N., Golks A., Riess D., Bentele M., Eils R., Krammer P.H. Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J Biol Chem 2007, 282:13664-13671.
56. Lavrik I.N., Krammer P.H. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ 2012, 19:36-41.
57. Lee J.K., Sayers T.J., Back T.C., Wigginton J.M., Wiltrout R.H. Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer. Apoptosis 2003, 2:151-160.
58. Lee Y.S., Choi I., Ning Y., Kim N.Y., Khatchadourian V., Yang D., et al. Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer 2012, 106:1833-1841.
59. Legembre P., Barnhart B.C., Zheng L., Vijayan S., Straus S.E., Puck J., et al. Induction of apoptosis and activation of NF-kB by CD95 require different signaling thresholds. EMBO Rep 2004, 5:1084-1089.
60. Lens S.M., Kataoka T., Fortner K.A., Tinel A., Ferrero I., MacDonald R.H., et al. The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 2002, 22:5419-5433.
61. Lesina M., Kurkowski M.U., Ludes K., Rose-John S., Treiber M., Kloppel G., et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011, 19:456-469.
62. Li H., Fan X., Stoicov C., Liu J.H., Zubair S., Tsai E., et al. Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver. Gastroenterology 2009, 137(934-944):944. e931-934.
63. Loberg R.D., Ying C., Craig M., Day L.L., Sargent E., Neeley C., et al. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res 2007, 67:9417-9424.
64. Lovatt D., Xu Q., Liu W., Takano T., Smith N.A., Schnermann J., et al. Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci U S A 2012, 109:6265-6270.
65. Lu Y., Chen Q., Corey E., Xie W., Fan J., Mizokami A., et al. Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin Exp Metastasis 2009, 26:161-169.
66. Luppi F., Longo A.M., de Boer W.I., Rabe K.F., Hiemstra P.S. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 2007, 56:25-33.
67. Mantovani A., Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010, 22:231-237.
68. Martin S.J., Henry C.M., Cullen S.P. A perspective on mammalian caspases as positive and negative regulators of inflammation. Mol Cell 2012, 46:387-397.
69. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
70. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
71. Mitsiades C.S., Poulaki V., Fanourakis G., Sozopoulos E., McMillin D., Wen Z., et al. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Clin Cancer Res 2006, 12:3705-3712.
72. Munakata S., Watanabe O., Ohashi K., Morino H. Expression of Fas ligand and bcl-2 in cervical carcinoma and their prognostic significance. Am J Clin Pathol 2005, 123:879-885.
73. Murdoch C., Muthana M., Coffelt S.B., Lewis C.E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008, 8:618-631.
74. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 1999, 33:29-55.
75. Nguyen V., Cudrici C., Zernetkina V., Niculescu F., Rus H., Drachenberg C., et al. TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects. Clin Immunol 2009, 132:32-42.
76. Ozturk S., Schleich K., Lavrik I.N. Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions. Exp Cell Res 2012, 318:1324-1331.
77. Palao G., Santiago B., Galindo M., Paya M., Ramirez J.C., Pablos J.L. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis Rheum 2004, 50:2803-2810.
78. Palao G., Santiago B., Galindo M.A., Rullas J.N., Alcami J., Ramirez J.C., et al. Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling. Arthritis Rheum 2006, 54:1473-1481.
79. Park D.R., Thomsen A.R., Frevert C.W., Pham U., Skerrett S.J., Kiener P.A., et al. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol 2003, 170:6209-6216.
80. Peter M.E., Budd R.C., Desbarats J., Hedrick S.M., Hueber A.-O., Newell M.K., et al. The CD95 receptor: apoptosis revisited. Cell 2007, 129:447-450.
81. Peter M.E., Krammer P.H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003, 10:26-35.
82. Pradeu T., Cooper E.L. The danger theory: 20 years later. Front Immunol 2012, 3:287-297.
83. Pylayeva-Gupta Y., Lee K.E., Hajdu C.H., Miller G., Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012, 21:836-847.
84. Qian B.Z., Li J., Zhang H., Kitamura T., Zhang J., Campion L.R., et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011, 475:222-225.
85. Rescigno M., Piguet V., Valzasina B., Lens S., Zubler R., French L., et al. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J Exp Med 2000, 192:1661-1668.
86. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., et al. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
87. Rensing-Ehl A., Malipiero U., Irmler M., Tschopp J., Constam D., Fontana A. Neurons induced to express the major histocompatability complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway. Eur J Immunol 1996, 26:2271-2274.
88. Rock K.L., Latz E., Ontiveros F., Kono H. The sterile inflammatory response. Annu Rev Immunol 2010, 28:321-342.
89. Sabelko K.A., Kelly K.A., Nahm M.H., Cross A.H., Russell J.H. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol 1997, 159:3096-3099.
90. Sakic B., Szechtman H., Denburg J.A., Gorny G., Kolb B., Whishaw I.Q. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J Neuroimmunol 1998, 87:162-170.
91. Schafer K.H., Mestres P., Marz P., Rose-John S. The IL-6/sIL-6R fusion protein hyper-IL-6 promotes neurite outgrowth and neuron survival in cultured enteric neurons. J Interf Cytokine Res 1999, 19:527-532.
92. Schneider P., Holler N., Bodmer J.L., Hahne M., Frei K., Fontana A., et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998, 187:1205-1213.
93. Sekine C., Yagita H., Kobata T., Hasunuma T., Nishioka K., Okumura K. Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis. Biochem Biophys Res Commun 1996, 228:14-20.
94. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., et al. Ordering the Cytochrome c-Initiated Caspase Cascade: Hierarchical Activation of Caspases -2, -3, -6, -7, -8 and -10 in a Caspase-9-Dependent Manner. J Cell Biol 1999, 144:281-292.
95. Sparmann A., Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004, 6:447-458.
96. Steller E.J., Borel Rinkes I.H., Kranenburg O. How CD95 stimulates invasion. Cell Cycle 2011, 10:3857-3862.
97. Steller E.J., Ritsma L., Raats D.A., Hoogwater F.J., Emmink B.L., Govaert K.M., et al. The death receptor CD95 activates the cofilin pathway to stimulate tumour cell invasion. EMBO Rep 2011, 12:931-937.
98. Strasser A., Jost P.J., Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009, 30:180-192.
99. Suda T., Hashimoto H., Tanaka M., Ochi T., Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 1997, 186:2045-2050.
100. Takahashi H., Ogata H., Nishigaki R., Broide D.H., Karin M. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 2010, 17:89-97.
101. Takamori H., Oades Z.G., Hoch O.C., Burger M., Schraufstatter I.U. Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1. Pancreas 2000, 21:52-56.
102. Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008, 9:231-241.
103. Trauzold A., Siegmund D., Schniewind B., Sipos B., Egberts J., Zorenkov D., et al. TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma. Oncogene 2006, 25:7434-7439.
104. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274:787-789.
105. Wajant H. The role of TNF in cancer. Results Probl Cell Differ 2009, 49:1-15.
106. Walczak H. TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunol Rev 2011, 244:9-28.
107. Waldner H., Sobel R.A., Howard E., Kuchroo V.K. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 1997, 159:3100-3103.
108. Wang C.Y., Mayo M.W., Baldwin A.S. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996, 274:784-787.
109. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281:1680-1683.
110. Waters J.P., Pober J.S., Bradley J.R. Tumour necrosis factor and cancer. J Pathol 2013, 230:241-248.
111. Wilson N.S., Dixit V., Ashkenazi A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 2009, 10:348-355.
112. Xu Q., Briggs J., Park S., Niu G., Kortylewski M., Zhang S., et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 2005, 24:5552-5560.
113. Zuliani C., Kleber S., Klussmann S., Wenger T., Kenzelmann M., Schreglmann N., et al. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ 2006, 13:31-40.
114. MacRedmond R., Singhera G.K., Dorscheid D.R. Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury. Eur Respir J 2009, 33:1403-1414.
115. Palao G., Santiago B., Galindo M.A., Rullas J.N., Alcami J., Ramirez J.C., et al. Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling. Arthritis Rheum 2006, 54:1473-1481.
116. O'Reilly L.A., Tai L., Lee L., Kruse E.A., Grabow S., Fairlie W.D., et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature 2009, 461:659-663.
117. Puthier D., Derenne S., Barille S., Moreau P., Harousseau J.L., Bataille R., et al. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells. Br J Haematol 1999, 107:392-395.
118. Teague T.K., Marrack P., Kappler J.W., Vella A.T. IL-6 rescues resting mouse T cells from apoptosis. J Immunol 1997, 158:5791-5796.
119. Ascherio A., Munger K., Lünemann D. The Initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012, 8:602-612.
120. de la Iglesia N., Konopka G., Lim K.L., Nutt C.L., Bromberg J.F., Frank D.A., et al. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neuro 2008, 28:5870-5878.
121. Knezevic-Cuca J., Stansberry K.B., Johnston G., Zhang J., Keller E.T., Vinik A.L., et al. J Neuroimmunol 2000, 102:8-16.